Image: USAID [CC BY-NC 2.0], via Flickr
South Africa’s collaboration with US-UK a concerted attempt to end vaccine’s need for cold-chain storage
Afrigen, a vaccine manufacturing and development consortium based in Cape Town, South Africa, has partnered with scientists in the United Kingdom and the United States to develop the world’s first heat-tolerant mRNA vaccine.
The project will focus on Hantaan Virus, which causes hemorrhagic fever with kidney disease, mainly in Asia and South America, and is becoming more common. There is currently no vaccine for the virus.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.